Therapeutic and Preventive Effects of Olea europaea Extract on Indomethacin-Induced Small Intestinal Injury Model in Rats

Abstract EN

Background.

Olea europaea (known as olive fruit) has anti-inflammatory and antioxidant activities and many potential health benefits including gastric inflammation reduction has been shown previously.

This study aimed to investigate the preventive and therapeutic effects of O.

europaea extract on the early histological changes in indomethacin-induced small intestinal injury model with the plasma D-lactate concentration being measured as a tool for determination of intestinal permeability.

Methods.

In this experimental study, two separate protective and therapeutic protocols were designed.

In both experiments, male Wistar rats were randomly divided into 4 groups and either pretreated with 0, 100, 200, or 400 mg/kg/day of O.

europaea extract or received the treatment after administration of indomethacin.

Their small intestines were examined to compare the histological changes.

The intestinal injury severity was evaluated according to the presence of eosinophils, plasma cell infiltration, edema, congestion, and hyperplasia of the crypt using a histological scoring system.

Also, measured were the presence of neutrophils, decreased villus length-to-crypt depth ratio, and destructed villus architecture.

The plasma concentration of D-lactate was measured as well.

Results.

The therapeutic use of O.

europaea decreased the eosinophil, edema, congestion, and crypt hyperplasia scores compared to the control group.

Although no significant difference was seen between groups of the preventive experiment in plasma cell infiltration score, villus length-to-crypt depth ratio, neutrophil infiltration, and percentage of destructed villus architecture, treatment with O.

europaea caused a reduction in edema, eosinophil, congestion, and crypt hyperplasia score.

In both experiments, no significant difference was seen between groups for villus length-to-crypt depth ratio, neutrophil infiltration, and percentage of destructed villus architecture.

Plasma D-lactate concentration was decreased in all O.

europaea-treated groups compared to the control group in the therapeutic and preventive experiments (p<0.01, one-way ANOVA followed by the Dunnett test).

Conclusion.

O.

europaea extract can be used to decrease some side effects of indomethacin on intestinal tissue and enhances the gastrointestinal function.

O.

europaea extract could be considered as a potential herbal supplement in the treatment of intestinal morphological injuries.